Informa (LON:INF) Given New GBX 1,285 Price Target at JPMorgan Chase & Co.

Informa (LON:INF) had its price objective reduced by JPMorgan Chase & Co. from GBX 1,300 to GBX 1,285 in a research report issued on Thursday,London Stock Exchange reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 41.02% from the company’s current price.

Separately, Citigroup dropped their price objective on shares of Informa from GBX 1,000 to GBX 850 and set a “neutral” rating for the company in a report on Thursday, April 9th. Five analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, Informa has a consensus rating of “Moderate Buy” and an average price target of GBX 1,093.33.

Informa Stock Down 0.5%

Shares of INF opened at GBX 911.20 on Thursday. Informa has a 52-week low of GBX 719 and a 52-week high of GBX 1,000. The company has a quick ratio of 1.70, a current ratio of 0.44 and a debt-to-equity ratio of 61.56. The stock has a fifty day simple moving average of GBX 824.98 and a two-hundred day simple moving average of GBX 831.37. The company has a market capitalization of £11.47 billion, a PE ratio of 1,139.00, a price-to-earnings-growth ratio of 0.75 and a beta of 0.71.

Insider Buying and Selling at Informa

In other Informa news, insider Gareth Wright purchased 222 shares of the firm’s stock in a transaction dated Wednesday, May 20th. The shares were acquired at an average price of GBX 809 per share, with a total value of £1,795.98. Also, insider Stephen A. Carter purchased 222 shares of the stock in a transaction dated Wednesday, May 20th. The shares were acquired at an average price of GBX 809 per share, with a total value of £1,795.98. Corporate insiders own 0.23% of the company’s stock.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.